Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Trifluoromethanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL6086975 | 1.00 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL8352480 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL2484799 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL7027061 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL1618610 | 0.96 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL30201668 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL63151 | 0.96 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL17510194 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL15569456 | 0.92 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL7636483 | 0.92 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798219-A | Preparation method of octreonazole | 长治医学院 | 2025-04-11 | — | — | CN | claimed |
| CN-108821974-B | Preparation method of alkoxy acrylate | 中国科学院兰州化学物理研究所 | 2020-10-27 | — | — | CN | claimed |
| CN-105102504-B | Radically polymerizable polyether, process for producing the same, polymerizable composition, copolymer, molded article, and film | 三菱化学株式会社 | 2017-08-04 | — | — | CN | claimed |
| US-9718919-B2 | Radically polymerizable polyether, method for producing said radically polymerizable polyether, polymerizable composition comprising said radically polymerizable polyether and radically polymerizable vinyl monomer, and copolymer, molded article and film each formed by radical polymerization of said polymerizable composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-08-01 | — | — | US | claimed |
| EP-2748224-B1 | METHOD OF PRODUCING HIGH VOLTAGE ELECTRICAL INSULATION | ABB RESEARCH LTD (CH) | 2017-07-05 | — | — | EP | claimed |
| US-20160002399-A1 | RADICALLY POLYMERIZABLE POLYETHER, METHOD FOR PRODUCING SAID RADICALLY POLYMERIZABLE POLYETHER, POLYMERIZABLE COMPOSITION COMPRISING SAID RADICALLY POLYMERIZABLE POLYETHER AND RADICALLY POLYMERIZABLE VINYL MONOMER, AND COPOLYMER, MOLDED ARTICLE AND FILM EACH FORMED BY RADICAL POLYMERIZATION OF SAID POLYMERIZABLE COMPOSITION | MITSUBISHI RAYON CO., LTD. (JP) | 2016-01-07 | — | — | US | claimed |
| CN-105102504-A | Radically polymerizable polyether, method for producing the radically polymerizable polyether, polymerizable composition containing the radically polymerizable polyether and radically polymerizable vinyl monomer, and copolymer, molded body, and film obtained by radically polymerizing the polymerizable composition | MITSUBISHI RAYON CO | 2015-11-25 | — | — | CN | claimed |
| US-20140329023-A1 | METHOD OF PRODUCING HIGH VOLTAGE ELECTRICAL INSULATION | ABB RESEARCH LTD. (CH) | 2014-11-06 | — | — | US | claimed |
| EP-2748224-A1 | METHOD OF PRODUCING HIGH VOLTAGE ELECTRICAL INSULATION | ABB Research Ltd. (CH) | 2014-07-02 | — | — | EP | claimed |
| WO-2013034193-A1 | METHOD OF PRODUCING HIGH VOLTAGE ELECTRICAL INSULATION | ABB RESEARCH LTD (CH) | 2013-03-14 | — | — | WO | claimed |
| CN-119798219-A | Preparation method of octreonazole | 长治医学院 | 2025-04-11 | — | — | CN | disclosed |
| CN-119403554-A | Therapeutic or prophylactic agent for amyotrophic lateral sclerosis | 东丽株式会社 | 2025-02-07 | — | — | CN | disclosed |
| US-20240425515-A1 | COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | CENTRE NAT RECH SCIENT (FR) | 2024-12-26 | — | — | US | disclosed |
| CN-114539201-B | Preparation method of Sibirer linking agent | 苏州昊帆生物股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-4367121-A1 | COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | Centre National de la Recherche Scientifique (FR) | 2024-05-15 | — | — | EP | disclosed |
| CN-1310709-A | N, N-substituted cyclic amine derivatives | EISAI CO LTD (JP) | 2001-08-29 | — | — | CN | disclosed |
| EP-1099692-A1 | N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES | Eisai Co., Ltd. (JP) | 2001-05-16 | — | — | EP | disclosed |
| JP-2000073014-A | 2-CYANOACRYLATE-BASED COMPOSITION | TOAGOSEI CO LTD | 2000-03-07 | — | — | JP | disclosed |
| US-5874595-A | SINGLE STEP, SELECTIVE ACETYLATION OF 10-DEACETYLBACCATIN III INTO BACCATIN III USING LEWIS ACID CATALYSTS IN THE REACTION WITH ACETIC ANHYDRIDE; PREPARATION OF TAXOL FROM BACCATIN III | PHARMACHEMIE B.V. (NL) | 1999-02-23 | — | — | US | disclosed |
| EP-0875508-A1 | Method for the preparation of baccatin III and derivatives thereof from 10-deacetylbaccatin III | PHARMACHEMIE B.V. (NL) | 1998-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425515-A1 | COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | HK1, HK2, C1R | ALDH1A1 1244/4885L3MBTL1 4070/4885CA1 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.